[go: up one dir, main page]

CN113368052A - Multiple emulsion of soyasaponin and preparation method thereof - Google Patents

Multiple emulsion of soyasaponin and preparation method thereof Download PDF

Info

Publication number
CN113368052A
CN113368052A CN202110595995.0A CN202110595995A CN113368052A CN 113368052 A CN113368052 A CN 113368052A CN 202110595995 A CN202110595995 A CN 202110595995A CN 113368052 A CN113368052 A CN 113368052A
Authority
CN
China
Prior art keywords
soybean
emulsion
water phase
oil
multiple emulsion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110595995.0A
Other languages
Chinese (zh)
Other versions
CN113368052B (en
Inventor
朱力杰
许杨杨
刘悦
宁淼
赵国秀
李赛楠
刘秀英
杨立娜
王胜男
刘贺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bohai University
Original Assignee
Bohai University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bohai University filed Critical Bohai University
Priority to CN202110595995.0A priority Critical patent/CN113368052B/en
Publication of CN113368052A publication Critical patent/CN113368052A/en
Application granted granted Critical
Publication of CN113368052B publication Critical patent/CN113368052B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113Multiple emulsions, e.g. oil-in-water-in-oil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Edible Oils And Fats (AREA)
  • Seasonings (AREA)

Abstract

一种大豆皂苷多重乳液及其制备方法,所述多重乳液为水包油包水结构,其外水相中含有大豆分离蛋白和磷酸盐缓冲溶液;油相含有聚甘油蓖麻醇酯和玉米油;内水相含有大豆皂苷和磷酸盐缓冲溶液;外水相中大豆分离蛋白的质量浓度为1%~3%;油相中聚甘油蓖麻醇酯的质量浓度为3%;内水相中大豆皂苷的质量浓度为1%。将油相与内水相进行混合、均质,得到W/O乳液;再将外水相与W/O乳液进行混合、均质,得到具有缓释功能的大豆皂苷多重乳液。优点是:稳定性好、分散均匀,可以有效对大豆皂苷进行包埋,且对大豆皂苷具有控释作用,避免其摄入后在胃酸等作用下,由于结构被破坏而失去活性,同时可遮蔽大豆皂苷的不良风味,具有良好的适口性。

Figure 202110595995

A soybean saponin multiple emulsion and a preparation method thereof, wherein the multiple emulsion is a water-in-oil-in-water structure, the outer water phase contains soybean protein isolate and phosphate buffer solution; the oil phase contains polyglycerol ricinoleate and corn oil The inner water phase contains soybean saponin and phosphate buffer solution; the mass concentration of soybean protein isolate in the outer water phase is 1% to 3%; the mass concentration of polyglycerol ricinoleate in the oil phase is 3%; The mass concentration of soybean saponin was 1%. The oil phase and the inner water phase are mixed and homogenized to obtain a W/O emulsion; and the outer water phase and the W/O emulsion are mixed and homogenized to obtain a soybean saponin multiple emulsion with slow release function. The advantages are: good stability, uniform dispersion, can effectively encapsulate soybean saponins, and have a controlled release effect on soybean saponins, avoiding the loss of activity due to the destruction of the structure under the action of gastric acid after ingestion, and can be shielded at the same time. The bad flavor of soybean saponins has good palatability.

Figure 202110595995

Description

Multiple emulsion of soyasaponin and preparation method thereof
Technical Field
The invention relates to a soyasaponin multiple emulsion and a preparation method thereof.
Background
The soyasaponin belongs to pentacyclic triterpenoid oleanane type saponin, is the most important micromolecule functional component in soybean, and is rich in soybean meal of a by-product extracted from soybean oil. The soyasaponin can activate an Nrf2/HO-1 signal path in a body, so that various antioxidant mechanisms of the body are excited, and various physiological effects of the body are realized; it has an enhancing effect on T cells, especially T cell function enhancement, and can increase IL-2 secretion for protecting survival and reproduction of T cells; and T cells are promoted to generate lymphokines, the differentiation of trap-killing cells NK is enhanced, the activity of LAK is improved, and therefore organisms show stronger immune functions. However, soyasaponin has certain irritation and bitter taste, and is not suitable for large-amount ingestion at one time; meanwhile, as a glycoside compound, the glycoside compound may be degraded by gastric acid and the like after being ingested, thereby affecting the exertion of the physiological activity.
Common saponin emulsions are mostly oil-in-water (O/W) and water-in-oil (W/O) types. Because the saponin has an amphiphilic structure and is relatively hydrophilic, the oil-in-water type saponin emulsion cannot effectively embed the saponin and is difficult to shield the bad flavor of the saponin; and the stability and the dispersibility of the water-in-oil saponin emulsion are poor.
Disclosure of Invention
The invention aims to provide the soyasaponin multiple emulsion with good stability and uniform dispersion and the preparation method thereof, which can effectively embed soyasaponin, have a controlled release effect on the soyasaponin, avoid the loss of activity of the soyasaponin due to the structural damage under the action of gastric acid and the like after being ingested, simultaneously can shield the bad flavor of the soyasaponin and have good palatability.
The technical scheme of the invention is that
A soyasaponin multiple emulsion is characterized in that: the multiple emulsion is of a water-in-oil-in-water structure, and the external water phase of the multiple emulsion contains isolated soy protein and phosphate buffer solution; the intermediate oil phase contains polyglycerol polyricinoleate and corn oil; the inner water phase contains soyasaponin and phosphate buffer solution; the mass concentration of the soybean protein isolate in the external water phase is 1-3%; the mass concentration of the polyglycerol polyricinoleate in the intermediate oil phase is 3%; the mass concentration of the soyasaponin in the internal water phase is 1%.
Further, the mass ratio of the intermediate oil phase to the inner water phase is 7: 3; the ratio of the mass of the external aqueous phase to the total mass of the intermediate oil phase and the internal aqueous phase is 6:4 or 5: 5.
Furthermore, the purity of the soyasaponin is more than 90%, and the mass content of the protein in the isolated soy protein is more than 80%.
Further, the phosphate buffer solution is a sodium dihydrogen phosphate buffer solution with a pH of 7.0.
Preparing a phosphate buffer solution: 1.1098g of disodium hydrogen phosphate dodecahydrate and 0.2964g of sodium dihydrogen phosphate dihydrate were dissolved in a 500ml volumetric flask to prepare a solution having a pH of 7.0.
The preparation method of the soybean saponin multiple emulsion comprises the following steps:
1) dissolving soyasaponin in phosphate buffer solution to obtain 1% inner water phase;
2) dissolving polyglycerol polyricinoleate in corn oil to prepare an oil phase with the polyglycerol polyricinoleate concentration of 3%;
3) mixing and homogenizing according to the mass ratio of the oil phase to the internal water phase of 7:3 to obtain W/O emulsion;
4) dissolving the isolated soy protein in phosphate buffer solution to prepare an external water phase with the mass fraction of the isolated soy protein being 2%;
5) mixing the external water phase with the W/O emulsion obtained in the step 3) according to the mass ratio of 6:4 or 5:5, and homogenizing to obtain the soyasaponin multiple emulsion with the slow release function.
Further, the polyglycerol polyricinoleate is dissolved in the corn oil, and is heated and stirred for 30min at 50 ℃.
Further, when the oil phase and the internal water phase are mixed, the mixture is homogenized at 18000r/min for 4min in a high-speed homogenizer, and then homogenized at 60MPa in a high-pressure homogenizer.
Further, when the external aqueous phase and the W/O emulsion were mixed, they were homogenized at 7000r/min for 2min in a high-speed homogenizer, and then homogenized at 10MPa in a high-pressure homogenizer, followed by high-pressure homogenization.
The invention has the beneficial effects that:
the water-in-oil-in-water multiple emulsion prepared by the method has controllable conditions, stable structure, proper particle size and good dispersibility, is stable when placed for 15 days at room temperature, has no layering phenomenon, is moderate in viscosity and good in palatability; the soybean saponin in the soybean saponin multiple emulsion is only released by 65.32% in 24h, and the release rate reaches 87.11% in 48h without basically changing, and the release rate is in a uniform and slow trend. The emulsion realizes the uniform release of soyasaponin within 24h, and has sustained release function within 24h to 48 h. After the soyasaponin is coated, the release of the soyasaponin functional substances is obviously slowed down, which shows that the soyasaponin multiple emulsion prepared by the invention has a slow release effect; and the damage of the soybean saponin to the in-vivo environment such as gastric acid and the like is avoided, and the bad flavor of the soybean saponin is shielded.
Drawings
The invention is further described with reference to the following figures and examples:
fig. 1 is a flow chart of the preparation of the soyasaponin multiple emulsion with a slow release function of the invention;
fig. 2 is a graph showing stability power index values of multiple emulsions of soyasaponin with sustained release function, which are composed of soyasaponin with different concentrations in example 1 and comparative examples 1 to 3 of the present invention;
FIG. 3 is a viscosity number curve diagram of multiple aqueous emulsions of soyasaponin with sustained release function, which are composed of different concentrations of soyasaponin in example 1 and comparative examples 1 to 3 of the present invention;
FIG. 4 is a diagram of multiple aqueous emulsions of soyasaponin with sustained release function, which are composed of different soyasaponin concentrations in example 1 and comparative examples 1-3 of the present invention (A is fresh emulsion; B is 15 days after emulsion);
FIG. 5 is a graph of the in vitro release rate of a 1% wt aqueous solution of soyasaponin and the multiple emulsion of example 1 of the present invention;
FIG. 6 is a graph of stability power index values for water-in-oil-in-water emulsions of examples 2-4, comparative example 4 at different concentrations of soy protein isolate;
FIG. 7 is a graph of viscosity values for water-in-oil-in-water emulsions of examples 2-4, comparative example 4 at different concentrations of soy protein isolate;
FIG. 8 is a visual representation of water-in-oil-in-water emulsions of examples 2-4 and comparative example 4 with different concentrations of soy protein isolate (A is fresh emulsion; B is emulsion after 15 days).
Detailed Description
The invention discloses a soyasaponin multiple emulsion with a slow release function and a preparation method thereof, wherein the mass concentration of soyasaponin in an internal water phase is 1%, and a solvent is a phosphate buffer solution with the pH value of 7; the mass concentration of the polyglycerol polyricinoleate in the intermediate oil phase is 3 percent, and the solvent is corn oil; the mass concentration of the isolated soy protein in the external water phase is 1-3%, and the solvent is phosphate buffer solution with pH 7. Wherein, phosphate buffer solution preparation: 1.1098g of disodium hydrogen phosphate dodecahydrate and 0.2964g of sodium dihydrogen phosphate dihydrate were dissolved in a 500ml volumetric flask to prepare a solution having a pH of 7.0. The specific operation steps are as follows: 1) dissolving 1g of soyasaponin in 99g of phosphate buffer solution (pH 7.0) as an internal aqueous phase; 2) dissolving 3g of polyglycerol polyricinoleate in 97g of corn oil, heating and stirring at 50 ℃ for 30min to prepare an oil phase; 3) according to the mass ratio of the oil phase to the internal water phase of 7:3, mixing, homogenizing for 4min at 18000r/min by a high-speed homogenizer, and then homogenizing at 60Mpa by a high-pressure homogenizer to obtain W/O emulsion; 4) then dissolving 1g-3g of soy protein isolate in 97g-99g of phosphate buffer solution as an external water phase with the mass of 100 g; 5) the mass ratio of the external aqueous phase to the W/O emulsion obtained in the step 3) is 6:4 or 5:5, mixing, homogenizing at 7000r/min for 2min with a high-speed homogenizer, homogenizing at 10Mpa with a high-pressure homogenizer, and homogenizing at high pressure to obtain the soyasaponin multiple emulsion with slow release function.
The present invention will be further explained with reference to specific examples, but is not limited to the scope of the present invention.
The phosphate buffer solution referred to in the following examples and comparative examples is sodium dihydrogen phosphate buffer solution with pH 7.0, which is specifically formulated as follows: 1.1098g of disodium hydrogen phosphate dodecahydrate and 0.2964g of sodium dihydrogen phosphate dihydrate are dissolved in a 500mL volumetric flask and added with water to a constant volume to prepare the sodium hydrogen phosphate dihydrate-sodium phosphate-sodium solid solution, wherein the pH value is 7.0. The purity of the used raw material soyasaponin is more than 90%, the mass content of the protein in the soybean protein isolate is more than 80%, and the same batch of products are used for ensuring the accuracy of the parallel test result.
Example 1
Table 1 shows the formula of the main composition of example 1, and the mass fractions of the substances are as follows:
emulsion composition Mass concentration of each substance
Internal aqueous phase Soyasaponin-phosphate buffer solution 1%
Oil phase Polyglycerol polyricinoleate-corn oil 3%
External water phase Isolated soy protein-phosphate buffer solution 2%
TABLE 1 EXAMPLE 1 composition formulation for Water-in-oil-in-Water emulsion
The procedure of this example, as shown in FIG. 1, was as follows:
(1) 1g of soybean saponin was dissolved in 99g of phosphate buffer solution (pH 7.0) as an internal aqueous phase.
(2) An oil phase was prepared by dissolving 3g of polyglycerol polyricinoleate in 97g of corn oil and heating and stirring at 50 ℃ for 30 min.
(3) Mixing the oil phase and the internal water phase according to the mass ratio of 7:3, homogenizing for 4min at 18000r/min in a high-speed homogenizer, and homogenizing the homogenized crude emulsion under high pressure at 60Mpa to obtain the final W/O emulsion.
(4) 2g of soy protein isolate was dissolved in 98g of phosphate buffered saline (pH 7.0) as an external aqueous phase.
(5) Mixing the external water phase and the W/O emulsion at a mass ratio of 6:4, homogenizing at 7000r/min for 2min with a high-speed homogenizer, and homogenizing at 10Mpa with a high-pressure homogenizer to obtain the soyasaponin multiple emulsion with slow release function. The particle size and width of the multiple emulsion were measured using a laser particle size distribution analyzer, and the results are shown in table 2.
TABLE 2
Sample name D43(μm) D32(μm) Span
Example 1 1% Soyasaponin 10.500±0.300c 3.347±0.053c 2.836±0.201b
Comparative example 1, the mass fraction of soyasaponin in the internal aqueous phase was 0.5%, and the remaining composition and preparation method were the same as in example 1.
(1) 0.5g of soybean saponin was dissolved in 99.5g of phosphate buffer solution (pH 7.0) as an internal aqueous phase.
(2) An oil phase was prepared by dissolving 3g of polyglycerol polyricinoleate in 97g of corn oil and heating and stirring at 50 ℃ for 30 min.
(3) Mixing the oil phase and the internal water phase according to the mass ratio of 7:3, homogenizing for 4min at 18000r/min in a high-speed homogenizer, and homogenizing the homogenized crude emulsion under high pressure at 60Mpa to obtain the final W/O emulsion.
(4) 2g of soy protein isolate was dissolved in 98g of phosphate buffered saline (pH 7.0) as an external aqueous phase.
(5) Mixing the external water phase and the W/O emulsion at a mass ratio of 6:4, homogenizing at 7000r/min for 2min with a high-speed homogenizer, and homogenizing at 10Mpa with a high-pressure homogenizer to obtain the soyasaponin multiple emulsion with slow release function.
Comparative example 2, the mass fraction of soyasaponin in the inner aqueous phase was 2%, and the remaining composition and preparation method thereof were the same as in example 1.
(1) 5g of soybean saponin was dissolved in 98g of phosphate buffer solution (pH 7.0) as an internal aqueous phase.
(2) An oil phase was prepared by dissolving 3g of polyglycerol polyricinoleate in 97g of corn oil and heating and stirring at 50 ℃ for 30 min.
(3) Mixing the oil phase and the internal water phase according to the mass ratio of 7:3, homogenizing for 4min at 18000r/min in a high-speed homogenizer, and homogenizing the homogenized crude emulsion under high pressure at 60Mpa to obtain the final W/O emulsion.
(4) 2g of soy protein isolate was dissolved in 98g of phosphate buffered saline (pH 7.0) as an external aqueous phase.
(5) Mixing the external water phase and the W/O emulsion at a mass ratio of 6:4, homogenizing at 7000r/min for 2min with a high-speed homogenizer, and homogenizing at 10Mpa with a high-pressure homogenizer to obtain the soyasaponin multiple emulsion with slow release function.
Comparative example 3, the mass fraction of soyasaponin in the inner aqueous phase was 3%, and the remaining composition and preparation method were the same as in example 1.
(1) 3g of soybean saponin was dissolved in 97g of phosphate buffer solution (pH 7.0) as an internal aqueous phase.
(2) An oil phase was prepared by dissolving 3g of polyglycerol polyricinoleate in 97g of corn oil and heating and stirring at 50 ℃ for 30 min.
(3) Mixing the oil phase and the internal water phase according to the mass ratio of 7:3, homogenizing for 4min at 18000r/min in a high-speed homogenizer, and homogenizing the homogenized crude emulsion under high pressure at 60Mpa to obtain the final W/O emulsion.
(4) 2g of soy protein isolate was dissolved in 98g of phosphate buffered saline (pH 7.0) as an external aqueous phase.
(5) Mixing the external water phase and the W/O emulsion at a mass ratio of 6:4, homogenizing at 7000r/min for 2min with a high-speed homogenizer, and homogenizing at 10Mpa with a high-pressure homogenizer to obtain the soyasaponin multiple emulsion with slow release function.
Stability power index and stability comparison of soyasaponin multiple emulsions with different concentrations
Fig. 2 shows stability power index values of multiple emulsions of water-in-oil-in-water soybean saponins composed of soybean saponins at different concentrations in example 1 and comparative examples 1 to 3 of the present invention. And (3) adopting a multiple light scattering instrument to carry out standing vertical scanning on the sample, and automatically calculating to obtain the stability dynamic index. The larger the numerical value of the stability kinetic index is, the worse the stability of the multiple emulsion of the soyasaponin is. As can be seen from fig. 2, the stability dynamic index of the multiple soybean saponin emulsion shows a trend of increasing with the time, and the stability dynamic index of the multiple soybean saponin emulsion increases with the increase of the concentration of the soybean saponin under the same standing time, which indicates that the stability of the emulsion is slightly reduced with the time of standing.
FIG. 4 is a graph of different concentrations of soyasaponin to form a water-in-oil-in-water emulsion. As can be seen from fig. 4(a), the fresh emulsions prepared in example 1 and comparative examples 1, 2 and 3 all appeared milky white, had good stability, and no saponin was precipitated; FIG. 4(B) shows that after 15d, no delamination was observed between the two emulsions of example 1 and comparative example 1; the results of the two emulsions of comparative examples 2 and 3, in which significant demixing was observed and a little precipitation was observed at the bottom of the bottle, indicate that the emulsions of comparative examples 2 and 3 had poor stability.
Combining the stability kinetics index of fig. 2 and the visual observation result of fig. 4, the emulsion prepared in example 1 of the present invention, i.e., at a soyasaponin concentration of 1%, has good stability.
Viscosity change of soyasaponin multiple emulsions with different concentrations
The viscosity of each set of water-in-oil-in-water emulsions was measured using a rheometer and the results are shown in table 3 and fig. 3.
TABLE 3 viscosity number of emulsions with different soyasaponin concentrations
Soyasaponin concentration K*10-3(Pa·s) n R2
Comparative example 1 0.5% 9.627±0.414c 0.885±0.007a 0.999±0.001b
Example 1 1% 6.110±0.853b 0.926±0.024b 0.997±0.001a
Comparative example 2 2% 4.080±0.340a 0.967±0.012c 1.000±0.000b
Comparative example 3 3% 4.050±0.000a 0.973±0.003c 1.000±0.000b
Table 3 and fig. 3 show the viscosity change of the emulsions of example 1 and comparative examples 1 to 3 for different concentrations of soyasaponin. As can be seen from Table 3 and FIG. 3, the viscosity of the emulsion is moderate in the case of example 1, and poor in the taste in the case of comparative example 1; the viscosities of comparative examples 2 and 3 were slightly lower. The soybean saponin multiple emulsion system has shear thinning behavior.
Example 2
(1) 1g of soybean saponin was dissolved in 99g of phosphate buffer solution (pH 7.0) as an internal aqueous phase.
(2) An oil phase was prepared by dissolving 3g of polyglycerol polyricinoleate in 97g of corn oil and heating and stirring at 50 ℃ for 30 min.
(3) Mixing the oil phase and the internal water phase according to the mass ratio of 7:3, homogenizing for 4min at 18000r/min in a high-speed homogenizer, and homogenizing the homogenized crude emulsion under high pressure at 60Mpa to obtain the final W/O emulsion.
(4) 1g of soy protein isolate was dissolved in 99g of phosphate buffered saline (pH 7.0) as an external aqueous phase.
(5) Mixing the external water phase and the W/O emulsion at a mass ratio of 5:5, homogenizing at 7000r/min for 2min with a high-speed homogenizer, and homogenizing at 10Mpa with a high-pressure homogenizer to obtain the soyasaponin multiple emulsion with slow release function. The particle size and width of the multiple emulsion of soyasaponin were measured using a laser particle size distribution analyzer, and the results are shown in table 4.
Example 3
(1) 1g of soybean saponin was dissolved in 99g of phosphate buffer solution (pH 7.0) as an internal aqueous phase.
(2) An oil phase was prepared by dissolving 3g of polyglycerol polyricinoleate in 97g of corn oil and heating and stirring at 50 ℃ for 30 min.
(3) Mixing the oil phase and the internal water phase according to the mass ratio of 7:3, homogenizing for 4min at 18000r/min in a high-speed homogenizer, and homogenizing the homogenized crude emulsion under high pressure at 60Mpa to obtain the final W/O emulsion.
(4) 2g of soy protein isolate was dissolved in 98g of phosphate buffered saline (pH 7.0) as an external aqueous phase.
(5) Mixing the external water phase and the W/O emulsion at a mass ratio of 5:5, homogenizing at 7000r/min for 2min with a high-speed homogenizer, and homogenizing at 10Mpa with a high-pressure homogenizer to obtain the soyasaponin multiple emulsion with slow release function. The particle size and width of the multiple emulsion of soyasaponin were measured using a laser particle size distribution analyzer, and the results are shown in table 4.
Example 4
(1) 1g of soybean saponin was dissolved in 99g of phosphate buffer solution (pH 7.0) as an internal aqueous phase.
(2) An oil phase was prepared by dissolving 3g of polyglycerol polyricinoleate in 97g of corn oil and heating and stirring at 50 ℃ for 30 min.
(3) Mixing the oil phase and the internal water phase according to the mass ratio of 7:3, homogenizing for 4min at 18000r/min in a high-speed homogenizer, and homogenizing the homogenized crude emulsion under high pressure at 60Mpa to obtain the final W/O emulsion.
(4) 3g of soy protein isolate was dissolved in 97g of phosphate buffered saline (pH 7.0) as an external aqueous phase.
(5) Mixing the external water phase and the W/O emulsion at a mass ratio of 5:5, homogenizing at 7000r/min for 2min with a high-speed homogenizer, and homogenizing at 10Mpa with a high-pressure homogenizer to obtain the soyasaponin multiple emulsion with slow release function. The particle size and width of the multiple emulsion of soyasaponin were measured using a laser particle size distribution analyzer, and the results are shown in table 4.
Table 4 examples 2-4 multiple aqueous emulsion particle size table
Concentration of isolated soy protein D43(μm) D32(μm) Span
Example 2 1% isolated soy protein 6.493±0.136b 3.012±0.070b 1.798±0.027c
Example 3 2% isolated soy protein 5.834±0.002a 2.900±0.008a 1.650±0.002a
Example 4 3% isolated soy protein 5.755±0.036a 2.905±0.033a 1.655±0.017a
As can be seen from Table 4, the soybean saponin multiple emulsions of examples 2-4 of the present invention have small and moderate overall particle size, ranging from 5.755 μm to 6.493 μm.
Comparative example 4
(1) 1g of soybean saponin was dissolved in 99g of phosphate buffer solution (pH 7.0) as an internal aqueous phase.
(2) An oil phase was prepared by dissolving 3g of polyglycerol polyricinoleate in 97g of corn oil and heating and stirring at 50 ℃ for 30 min.
(3) Mixing the oil phase and the internal water phase according to the mass ratio of 7:3, homogenizing for 4min at 18000r/min in a high-speed homogenizer, and homogenizing the homogenized crude emulsion under high pressure at 60Mpa to obtain the final W/O emulsion.
(4) 0.5g of soy protein isolate was dissolved in 99.5g of phosphate buffered saline (pH 7.0) as the external aqueous phase.
(5) Mixing the external water phase and the W/O emulsion at a mass ratio of 5:5, homogenizing at 7000r/min for 2min with a high-speed homogenizer, and homogenizing at 10Mpa with a high-pressure homogenizer to obtain the soyasaponin multiple emulsion with slow release function.
FIG. 6 is a graph of stability power index values of multiple emulsions of soyasaponin composed of different concentrations of soy protein isolate of examples 2-4 and comparative example 4. As can be seen from fig. 6, as the concentration of the soy protein isolate increases, the stability dynamic index of the emulsion shows a tendency to decrease, the stability of the emulsion is continuously enhanced, and the stability of comparative example 4 is inferior to examples 2, 3 and 4.
Table 5 and fig. 7 the results of multiple emulsions of soyasaponin were constructed with different concentrations of soy protein isolate in examples 2-4 and comparative example 4.
TABLE 5 Effect of different soy protein isolate concentrations on the viscosity of water-in-oil-in-water emulsions
Concentration of isolated soy protein K(Pa·s) n R2
Comparative example 4 0.5% isolated soy protein 0.011±0.001a 0.843±0.012c 0.998±0.000a
Example 2 1% isolated soy protein 0.029±0.005b 0.731±0.025b 0.999±0.001b
Example 3 2% isolated soy protein 0.032±0.004b 0.723±0.018ab 0.999±0.000b
Example 4 3% isolated soy protein 0.043±0.003c 0.696±0.010a 0.999±0.000b
The results in table 5 and figure 7 show that as the concentration of soy protein isolate increases, the viscosity of the emulsion increases accordingly. Where the viscosity of comparative example 4 is too low, the viscosities of examples 2, 3 are relatively close, and the viscosity of example 4 is slightly greater than examples 2, 3, but still acceptable.
FIG. 8 is a visual photograph of different soy protein isolate concentrations making up a water-in-oil-in-water emulsion. As can be seen from fig. 8(a), the freshly prepared emulsion appeared uniformly milky white, and no precipitation of a precipitate was observed; and FIG. 8(B) shows that comparative example 4 shows a severe destabilization stratification after standing for 15d, indicating that 0.5% of the soy protein isolate does not meet the requirements for stable emulsion. The results of examples 2, 3 and 4 show that when the mass fraction of the isolated soy protein is 1-3%, a stable water-in-oil-in-water emulsion of the soyasaponin can be prepared, and the effect of example 3 is optimal.
Third, example 1 sustained Release function of Soyasaponin
The results of comparing the in vitro release rates of the aqueous solution of soyasaponin and the soyasaponin multiple emulsion having a sustained-release function of example 1 of the present invention are shown in fig. 5. The soyasaponin multiple emulsion with sustained release function prepared in this example 1 was selected to perform in vitro release experiments. Placing 5mL of soybean saponin multiple emulsion with slow release function and 1% soybean saponin aqueous solution in dialysis bag, placing into a conical flask containing 100mL of release medium (ultrapure water), shaking at low speed in a constant temperature shaking table at 37 deg.C, and taking 1mL of sample at a certain time interval (0.5, 1, 2, 4, 8, 12, 24, 36, 48h) to supplement the same volume of release medium. The content of the soyasaponin in the sample is analyzed by adopting a vanillin-glacial acetic acid method. The results in fig. 5 show that the release of the soyasaponin in the ultrapure water is completed within about 5 hours, while the release rate of the soyasaponin in the water-in-oil-in-water emulsion is only 65.32% within 24 hours, and reaches 87.11% within 48 hours, and basically does not change any more, and the release rate is in a uniform and slow trend compared with the release rate of the control group. The results show that the emulsion realizes the uniform release of the soyasaponin within 24 hours and has the slow release function within the range of 24 hours to 48 hours.
The above description is only exemplary of the present invention and is not intended to limit the present invention, and various modifications and changes may be made by those skilled in the art. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims (8)

1.一种大豆皂苷多重乳液,其特征是:所述多重乳液为水包油包水结构,其外水相中含有大豆分离蛋白和磷酸盐缓冲溶液;中间油相含有聚甘油蓖麻醇酯和玉米油;内水相含有大豆皂苷和磷酸盐缓冲溶液;该多重乳液对大豆皂苷具有缓释功能,水相中大豆分离蛋白的质量浓度为1%~3%;中间油相中聚甘油蓖麻醇酯的质量浓度为3%;内水相中大豆皂苷的质量浓度为1%。1. a soybean saponin multiple emulsion is characterized in that: the multiple emulsion is a water-in-oil-in-water structure, and contains soybean protein isolate and phosphate buffer solution in its outer water phase; the middle oil phase contains polyglycerol ricinoleate and corn oil; the inner water phase contains soybean saponin and phosphate buffer solution; the multi-emulsion has a slow-release function for soybean saponins, and the mass concentration of soybean protein isolate in the water phase is 1% to 3%; the polyglycerol castor in the middle oil phase The mass concentration of estroleum ester is 3%; the mass concentration of soybean saponin in the inner water phase is 1%. 2.根据权利要求1所述的大豆皂苷多重乳液,其特征是:所述中间油相与内水相的质量比为7:3;外水相的质量与中间油相和内水相的总质量比值为6:4或5:5。2. soybean saponin multiple emulsion according to claim 1, is characterized in that: the mass ratio of described middle oil phase and inner water phase is 7:3; The mass ratio is 6:4 or 5:5. 3.根据权利要求1所述的大豆皂苷多重乳液,其特征是:所述大豆皂苷纯度>90%,大豆分离蛋白中蛋白质量含量>80%。3 . The soybean saponin multiple emulsion according to claim 1 , wherein the soybean saponin purity is greater than 90%, and the protein content in soybean protein isolate is greater than 80%. 4 . 4.根据权利要求1所述的大豆皂苷多重乳液,其特征是:所述磷酸盐缓冲溶液为pH为7.0的磷酸二氢钠缓冲液。4 . The soybean saponin multiple emulsion according to claim 1 , wherein the phosphate buffer solution is a sodium dihydrogen phosphate buffer solution with a pH of 7.0. 5 . 5.一种如权利要求1所述的大豆皂苷多重乳液的制备方法,其特征是:5. a preparation method of soybean saponin multiple emulsion as claimed in claim 1, is characterized in that: 包括以下步骤:Include the following steps: 1)将大豆皂苷按照溶解在磷酸盐缓冲溶液中,配制成大豆皂苷质量分数为1%的内水相;1) Dissolving the soybean saponin in a phosphate buffer solution, preparing the inner water phase with a soybean saponin mass fraction of 1%; 2)将聚甘油蓖麻醇酯溶于玉米油中,制成聚甘油蓖麻醇酯浓度为3%的油相;2) dissolving polyglycerol ricinoleate in corn oil, making the oil phase that the polyglycerol ricinoleate concentration is 3%; 3)按照油相与内水相质量比7:3进行混合、均质,得到W/O乳液;3) mix and homogenize according to the mass ratio of oil phase and inner water phase at 7:3 to obtain W/O emulsion; 4)再将大豆分离蛋白溶于磷酸盐缓冲溶液,配制成大豆分离蛋白质量分数为2%的外水相;4) Dissolving soybean protein isolate in phosphate buffer solution again to prepare an outer water phase with a soybean protein isolate mass fraction of 2%; 5)外水相与步骤3)得到的W/O乳液以质量比6:4或5:5进行混合、均质,得到具有缓释功能的大豆皂苷多重乳液。5) The outer water phase and the W/O emulsion obtained in step 3) are mixed and homogenized in a mass ratio of 6:4 or 5:5 to obtain a soybean saponin multiple emulsion with slow-release function. 6.根据权利要求5所述的大豆皂苷多重乳液的制备方法,其特征是:将聚甘油蓖麻醇酯溶于玉米油时,在50℃下加热搅拌30min。6. The preparation method of soybean saponin multiple emulsion according to claim 5, is characterized in that: when polyglycerol ricinole ester is dissolved in corn oil, heating and stirring at 50 DEG C for 30min. 7.根据权利要求5所述的大豆皂苷多重乳液的制备方法,其特征是:将油相与内水相混合时,在高速均质机下以18000r/min下均质4min,之用高压均质机在60Mpa压力下,进行高压均质。7. the preparation method of soybean saponin multiple emulsion according to claim 5 is characterized in that: when oil phase is mixed with inner water phase, under high-speed homogenizer, homogenize 4min at 18000r/min, and use high-pressure homogenizer. The mass machine performs high-pressure homogenization under the pressure of 60Mpa. 8.根据权利要求5所述的大豆皂苷多重乳液的制备方法,其特征是:将外水相与W/O乳液混合时,在高速均质机下以7000r/min均质2min,然后用高压均质机在10Mpa压力下均质,进行高压均质。8. the preparation method of soybean saponin multiple emulsion according to claim 5 is characterized in that: when external water phase is mixed with W/O emulsion, under high-speed homogenizer, homogenize 2min with 7000r/min, then use high pressure The homogenizer is homogenized under a pressure of 10Mpa, and high-pressure homogenization is performed.
CN202110595995.0A 2021-05-29 2021-05-29 Multiple emulsion of soyasaponin and preparation method thereof Active CN113368052B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110595995.0A CN113368052B (en) 2021-05-29 2021-05-29 Multiple emulsion of soyasaponin and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110595995.0A CN113368052B (en) 2021-05-29 2021-05-29 Multiple emulsion of soyasaponin and preparation method thereof

Publications (2)

Publication Number Publication Date
CN113368052A true CN113368052A (en) 2021-09-10
CN113368052B CN113368052B (en) 2022-12-30

Family

ID=77574927

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110595995.0A Active CN113368052B (en) 2021-05-29 2021-05-29 Multiple emulsion of soyasaponin and preparation method thereof

Country Status (1)

Country Link
CN (1) CN113368052B (en)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
徐清莹: "大豆皂苷-大豆7S/11S 蛋白复合体系的油-水界面行为及其乳液稳定性研究", 《中国知网》 *

Also Published As

Publication number Publication date
CN113368052B (en) 2022-12-30

Similar Documents

Publication Publication Date Title
US20080261927A1 (en) Stable Aqueous Suspension
CN108618146B (en) Soybean protein-stevioside composite stable phytosterol nano emulsion and preparation method and application thereof
CN102614091B (en) Resveratrol nanostructured lipid carrier and preparation method thereof
CN114831957B (en) Diglyceride microcapsule prepared by Maillard reaction product and preparation method thereof
CN101244053B (en) Novel dispersed system with docetaxel as main component
CN103006751B (en) Medium and long chain fat emulsion injection and preparation method thereof
CN113647627A (en) A kind of powder grease and preparation method thereof
CN106174598A (en) A kind of egg albumen powder of enhancing immunity
CN1887270A (en) Nanometer berberine hydrochloride emulsion and its prepn process
CN112641821A (en) Formula of fat emulsion injection and preparation method thereof
CN104686812A (en) Preparation method of nano vitamin D3 for coating of feed
CN113368052A (en) Multiple emulsion of soyasaponin and preparation method thereof
DK173596B1 (en) Emulsion for parenteral administration
CN113826906A (en) Dihydroquercetin nanoemulsion and preparation method and application thereof
CN115844837B (en) Astaxanthin nanoparticles with organ targeting and preparation method and application thereof
JP2014047189A (en) Superfine powder-containing capsule agent
CN116058497A (en) High-protein nutrition emulsion and preparation method thereof
KR102205300B1 (en) Process for the preparation of water-dispersible hybrid suspensions of insoluble or fat-soluble substances
CN109157549A (en) EGCG G. lucidum spores Softgel and preparation method thereof
CN105770902A (en) Omega-3 fish oil middle-long chain fat emulsion injection pharmaceutical composition and preparation method thereof
CN115006347B (en) D-galactose modified alpha-linolenic acid liver targeting nanoemulsion and preparation method and application thereof
CN109260149B (en) Nano emulsion containing gamma-tocotrienol and preparation method and application thereof
CN113229369A (en) sn-2 saturated fatty acid active structured lipid composition and preparation method and application thereof
CN113730351A (en) A kind of high stability emulsion of high load cannabidiol and preparation method thereof
CN116406785B (en) A stabilizing system for emulsion of special medical formula food

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant